de Oliveira Lula Estevam Carlos, de Oliveira Lula Carlos Estevam, Alves Cláudia Maria Coelho, Lopes Fernanda Ferreira, Pereira Antônio Luiz Amaral
Health Sciences Center, Federal University of Maranhão, São Luís, MA, Brazil.
Int J Pediatr Otorhinolaryngol. 2007 Nov;71(11):1681-5. doi: 10.1016/j.ijporl.2007.07.006. Epub 2007 Sep 11.
The adverse effects of chemotherapy frequently involve the oral cavity, but the severity of oral complications caused by different chemotherapy protocols is unknown.
To compare the frequency of oral complications in patients with acute lymphoblastic leukemia treated with the GBTLI-93 and BFM protocols.
Twenty patients ranging in age from 2 to 13 years were submitted to visual and tactile examination of the teeth, periodontium and soft tissues on the day of admission and over the 3 weeks following the first phase of chemotherapy.
No significant difference in the proportion of patients with complications was observed between the two protocols over the 3 weeks. Complications were more frequent immediately after administration of the chemotherapeutic agents, with a gradual decline over the following 3 weeks.
Oral complications occur in patients with acute lymphoblastic leukemia irrespective of the chemotherapy protocol used for treatment, with a higher frequency being observed in the first week after the beginning of antineoplastic therapy.
化疗的不良反应常累及口腔,但不同化疗方案所致口腔并发症的严重程度尚不清楚。
比较采用GBTLI - 93方案和BFM方案治疗的急性淋巴细胞白血病患者口腔并发症的发生率。
20例年龄在2至13岁的患者在入院当天及化疗第一阶段后的3周内接受了牙齿、牙周组织和软组织的视诊和触诊检查。
在3周内,两种方案的并发症患者比例无显著差异。化疗药物给药后即刻并发症更为频繁,在随后的3周内逐渐减少。
急性淋巴细胞白血病患者无论采用何种化疗方案进行治疗都会发生口腔并发症,在抗肿瘤治疗开始后的第一周发生率更高。